We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$97B
AUM Growth
-$517M
Cap. Flow
-$315M
Cap. Flow %
-0.32%
Top 10 Hldgs %
37.18%
Holding
506
New
13
Increased
130
Reduced
158
Closed
20

Top Buys

Rank Stock Value
1
ESTC icon
Elastic
ESTC
+$386M
2
MELI icon
Mercado Libre
MELI
+$307M
3
NU icon
Nu Holdings
NU
+$265M
4
SHOP icon
Shopify
SHOP
+$254M
5
RBLX icon
Roblox
RBLX
+$253M

Top Sells

Rank Stock Value
1
BYND icon
Beyond Meat
BYND
+$232M
2
LI icon
Li Auto
LI
+$219M
3
ILMN icon
Illumina
ILMN
+$187M
4
ALB icon
Albemarle
ALB
+$178M
5
RACE icon
Ferrari
RACE
+$147M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.03%
2 Healthcare 24.31%
3 Technology 16.9%
4 Communication Services 11.22%
5 Financials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLNK icon
426
Blink Charging
BLNK
$87.9M
$7K ﹤0.01%
396
+69
+21% +$1.42K
BMRN icon
427
BioMarin Pharmaceuticals
BMRN
$12.4B
$7K ﹤0.01%
82
EGHT icon
428
8x8 Inc
EGHT
$332M
$7K ﹤0.01%
2,045
NKE icon
429
Nike
NKE
$61.9B
$7K ﹤0.01%
90
WSM icon
430
Williams-Sonoma
WSM
$29.6B
$7K ﹤0.01%
126
NVRO
431
DELISTED
NEVRO CORP.
NVRO
$7K ﹤0.01%
154
ATEX icon
432
Anterix
ATEX
$1.94B
$6K ﹤0.01%
162
CSTL icon
433
Castle Biosciences
CSTL
$979M
$6K ﹤0.01%
225
DOMO icon
434
Domo
DOMO
$184M
$6K ﹤0.01%
321
KYNB
435
Kyntra Bio
KYNB
$29.4M
$6K ﹤0.01%
19
FOLD
436
DELISTED
Amicus Therapeutics
FOLD
$6K ﹤0.01%
538
HI
437
DELISTED
Hillenbrand
HI
$6K ﹤0.01%
170
MATV icon
438
Mativ Holdings
MATV
$711M
$6K ﹤0.01%
265
MNTV
439
DELISTED
Momentive Global Inc. Common Stock
MNTV
$6K ﹤0.01%
1,095
SRNE
440
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$6K ﹤0.01%
3,711
-603
-14% -$1.37K
AGIO icon
441
Agios Pharmaceuticals
AGIO
$1.93B
$5K ﹤0.01%
186
BLUE
442
DELISTED
bluebird bio
BLUE
$5K ﹤0.01%
43
CERS icon
443
Cerus
CERS
$474M
$5K ﹤0.01%
1,459
LBRDK icon
444
Liberty Broadband Class C
LBRDK
$5.15B
$5K ﹤0.01%
70
LSPD icon
445
Lightspeed Commerce
LSPD
$1.35B
$5K ﹤0.01%
310
OM icon
446
Outset Medical
OM
$90.8M
$5K ﹤0.01%
20
OXM icon
447
Oxford Industries
OXM
$552M
$5K ﹤0.01%
55
RARE icon
448
Ultragenyx Pharmaceutical
RARE
$2.55B
$5K ﹤0.01%
115
VUZI icon
449
Vuzix
VUZI
$224M
$5K ﹤0.01%
924
SUMO
450
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$5K ﹤0.01%
726

Similar funds

Baillie Gifford & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Baillie Gifford & Co held 506 positions worth $97B, down 0.53% from $97.5B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Baillie Gifford & Co's Q3 2022 filing shows 13 new, 130 increased, 158 reduced and 20 closed positions. Its largest new stake was Elastic: 4,847,733 shares worth $348M. The largest sale was Beyond Meat, an estimated $232M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q3 2022 buy was Elastic: 4,847,733 shares worth $348M.
  • Baillie Gifford & Co added most to Mercado Libre in Q3 2022, an estimated $307M increase.
  • Baillie Gifford & Co's biggest Q3 2022 reduction was Beyond Meat, cutting an estimated $232M.
  • Baillie Gifford & Co fully exited Zai Lab in Q3 2022, selling an estimated $25.5M.
  • Baillie Gifford & Co's ten largest holdings make up 37% of its $97B portfolio in Q3 2022.
  • Baillie Gifford & Co opened 13 new positions and closed 20 in Q3 2022.
  • Baillie Gifford & Co's portfolio value fell 0.53% quarter-over-quarter to $97B.

Based on Baillie Gifford & Co's 13F filing for Q3 2022, filed 27 Oct 2022.